Shares of Sotera Health Company (SHC) are surging 7.48% in pre-market trading on Thursday following the company's impressive first-quarter 2025 earnings report. The healthcare services provider delivered results that surpassed analysts' expectations on multiple fronts.
Sotera Health reported adjusted earnings per share of $0.14, beating the consensus estimate of $0.12. Revenue for the quarter came in at $254.5 million, exceeding Wall Street's projection of $245.8 million. The company's Adjusted EBITDA of $121.8 million also outperformed expectations, with a margin of 47.9% that was notably higher than anticipated.
Adding to investor optimism, Sotera Health reaffirmed its full-year 2025 outlook. The company continues to project net revenue growth of 4.0% to 6.0% and Adjusted EBITDA growth of 4.5% to 6.5%, both on a constant currency basis. Chairman and CEO Michael B. Petras, Jr. expressed satisfaction with the results, stating, "We are pleased to report a solid start to the year with mid-single digit revenue growth and strong double digit Adjusted EBITDA growth, on a constant currency basis." The combination of strong quarterly performance and maintained guidance appears to be driving the stock's significant pre-market rally.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.